Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term effects of amantadine withdrawal in Parkinson's disease patients with levodopa-induced dyskinesia
2006-006684-22Phase 4Active
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Parkinson's disease (PD) comparing Amantadine continuation with Amantadine withdrawal with placebo (2 arms). Started Mar 2007; status: active.
02
Drugs
amantadine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2006-006684-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006684-22.